This content is from: Premium
Elliott Versus Greenlight, Round Two
Why Elliott is all in on the shares of Bayer, which Greenlight unloaded in the first quarter.
One activist’s trash is another activist’s treasure.This, at least, is the case with Bayer AG, the German life sciences company that last year made an ill-fated acquisition of agricultural giant Monsanto. That company has suffered a slew of lawsuits alleging that its Roundup weed killer causes cancer, leading its stock
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.